Ledger.Open graph →
SEC Form D · filed October 25, 2018

Tivorsan Pharmaceuticals, Inc

Offering
$2.8M
Sold
$2.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LOS ANGELES, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Justin Fallon · Los Angeles, CADirectorMichael Meyers · Los Angeles, CAExecJay Venkatesan · Los Angeles, CADirectorJoel Braunstein · Los Angeles, CADirectorJohn Nicholson · Los Angeles, CADirectorJames Connolly · Los Angeles, CADirectorRichard Gomel · New York, NYDirectorLawrence Fuchs · New York, NYDirectorScott R. Lennon · George Town, Grand Cayman, Cayman IslandsExecGarland E. Faist · Chevy Chase, MDDirectorAlberto R. Gonzales · George Town, Grand Cayman, Cayman IslandsDirectorBenoit G. Sansoucy · Grand Cayman, Cayman IslandsDirectorDavid M. Kelly · Dublin, IrelandDirectorCorey N. Fishman · Dublin, IrelandDirectorJudith M. Matthews · Dublin, IrelandDirectorMichael M. Dunne · Dublin, IrelandExecPriscilla R. Sims-Brown · New York, NYDirectorChandra L. Arandjelovic · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗